Effectiveness of Serratus Posterior Superior Intercostal Plane Block in Robotic-Assisted Thoracoscopic Surgery for Thymectomy A Randomized Controlled Treatment Study

What this Trial Is About

Researchers are evaluating the Serratus Posterior Superior Intercostal Plane Block SPSIP Block to manage postoperative pain, reduce opioid use, minimize respiratory complications, and improve patient satisfaction after robotic thymectomy surgery. This randomized controlled trial compares patients receiving the SPSIP Block with those who do not, focusing on outcomes like pain intensity and quality of recovery. All participants will receive the SPSIP Block guided by ultrasound 15 minutes before surgery. Half the patients will receive 30 ml of 0.25% bupivacaine as active treatment, while the other half will receive a placebo saline solution. All patients will also receive paracetamol and ketorolac at the end of surgery and have access to a patient-controlled analgesia pump with opioids postoperatively. Rescue doses of paracetamol are provided if pain scores remain high. Participants will be assessed for pain levels at multiple times up to 24 hours after surgery, both at rest and during coughing. Researchers will track opioid use, rescue medication, respiratory complications, hospital stay length, and patient satisfaction using the QoR-15 questionnaire. The study maintains blinding for patients and investigators and includes thorough postoperative monitoring to evaluate recovery and safety.

Serratus Posterior Superior Intercostal Plane Block in Robotic-Assisted Thymectomy